SEC Form 4 · accession 0001209191-16-107452
TANDEM DIABETES CARE INC · TNDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John F Sheridan
Officer — EVP, CHIEF OPERATING OFFICER
Period of report
Mar 7, 2016
Accepted (ET)
Mar 9, 2016 · 6:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 7, 2016 | M | 4,000 | $1.1059 | A | 9,295 | D | |
| Common StockF1 | Mar 7, 2016 | S | 4,000 | $10.0065 | D | 5,295 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2 | $1.1059 | Mar 7, 2016 | M | 4,000 | D | Feb 25, 2014 | Apr 23, 2023 | Common Stock | 4,000 | 106,040 | D |
Explanation of responses
- F1The price reported is the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 3, 2015, in multiple transactions at prices ranging from $10.00 to $10.09. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- F2The option became 25% exercisable on 2/25/2014 and in 36 equal monthly installments thereafter.